Patents by Inventor Frederic Batteux

Frederic Batteux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of metal ions to potentiate the therapeutic effects of arsenic
    Publication number: 20220226372
    Abstract: The present disclosure relates to a combination of an arsenic compound and a metal ion, for use as a medicament, wherein the metal ion increases the therapeutic effects of arsenic.
    Type: Application
    Filed: May 20, 2020
    Publication date: July 21, 2022
    Applicant: MEDSENIC
    Inventors: Francois RIEGER, Frédéric BATTEUX
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
    Publication number: 20180364233
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of systemic sclerosis. In particular, the present invention relates to a method of treating systemic sclerosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of vanin-1 inhibitor.
    Type: Application
    Filed: December 7, 2016
    Publication date: December 20, 2018
    Inventors: Philippe NAQUET, Frédéric BATTEUX, Niloufar KAVIAN
  • Use of Mangafodipir for treating oxidative stress effects
    Patent number: 7351722
    Abstract: The invention concerns the use of Mangafodipir to obtain a medicine for preventive or curative treatment of hepatocellular deficiencies.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: April 1, 2008
    Assignee: Universite Rene Descartes (Paris V)
    Inventors: Frederic Batteux, Bernard Weill
  • Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
    Publication number: 20070148154
    Abstract: The invention relates to the use of superoxide dismutase mimetics and reductase glutathione (preferably Mangafodipir) in order to produce an anticancer drug. Said mimetic, in particular makes it possible to potentiate the actions of antitumoral agents generating active oxygen forms on tumoral cells and to protect non-tumoral cells against said actions.
    Type: Application
    Filed: December 17, 2004
    Publication date: June 28, 2007
    Applicants: UNIVERSITE RENE DESCARTES (PARIS V), PROTEXEL
    Inventors: Bernard Weill, Frederic Batteux, Alexis Laurent
  • Use of mangafodipir for treating oxidative stress effects
    Publication number: 20040142907
    Abstract: The invention concerns the use of Mangafodipir to obtain a medicine for preventive or curative treatment of hepatocellular deficiencies.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 22, 2004
    Inventors: Frederic Batteux, Bernard Weill
  • Il-6 detection for predicting risks of preterm delivery
    Publication number: 20040014063
    Abstract: The invention concerns a method for forecasting impending preterm delivery by detecting the presence or absence of IL-6 in a cervicovaginal secretion sample, in particular by detecting IL-6 mRNA by PCR or by direct detection of IL-6 through immuno-chromatography.
    Type: Application
    Filed: July 29, 2003
    Publication date: January 22, 2004
    Inventors: Frederic Batteux, Emmanuel Claret, Helene Trebeden, Claudine Vermot-Desroches, Bernard Weill, John Wijdenes
  • Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
    Publication number: 20030118577
    Abstract: The invention concerns the use of a compound having a superoxide dismustase activity, in particular a non-peptide analogue of the superoxide dismutase to obtain a medicine for preventive or curative treatment of hepatocellular insufficiency. Said medicine can be used in particular for treating hepatocellular insufficiencies of toxic or viral origin.
    Type: Application
    Filed: February 3, 2003
    Publication date: June 26, 2003
    Inventors: Bernard Weill, Frederic Batteux, Pierre-Jacques Ferret